Related references
Note: Only part of the references are listed.Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9
Seiko Yoshino et al.
BLOOD (2021)
Sulfur-Coordinated Organoiridium(III) Complexes Exert Breast Anticancer Activity via Inhibition of Wnt/β-Catenin Signaling
Qi Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
Yu Zhang et al.
ONCOGENE (2021)
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu et al.
CELL DEATH & DISEASE (2021)
The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
Kurt Sartorius et al.
FRONTIERS IN IMMUNOLOGY (2021)
Competing endogenous RNAs in lung cancer
Median Zhao et al.
CANCER BIOLOGY & MEDICINE (2021)
Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression
Junhui Xue et al.
CANCER LETTERS (2020)
ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells
Adriana C. Rodriguez et al.
CANCER RESEARCH (2020)
Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription
Debora Salerno et al.
GUT (2020)
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis
Zhi-Qiang Hu et al.
HEPATOLOGY (2020)
Intratumoral heterogeneity and clonal evolution in liver cancer
Bojan Losic et al.
NATURE COMMUNICATIONS (2020)
Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms
Jia Qunying et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
Catherine de Martel et al.
LANCET GLOBAL HEALTH (2020)
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion
Rakhee Bajaj et al.
ONCOGENE (2020)
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
Beng Yang et al.
ONCOGENE (2020)
HBV induced hepatocellular carcinoma and related potential immunotherapy
Liyang Jia et al.
PHARMACOLOGICAL RESEARCH (2020)
A compendium of mutational cancer driver genes
Francisco Martinez-Jimenez et al.
NATURE REVIEWS CANCER (2020)
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
Ruiqi Liu et al.
CANCER LETTERS (2019)
LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex
Wei Song et al.
CELL PROLIFERATION (2019)
PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway
Qiu-Xia Yang et al.
CANCER LETTERS (2019)
Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network
Ping-Hsing Tsai et al.
NUCLEIC ACIDS RESEARCH (2019)
H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 Histone Tags Suggest Distinct Regulatory Evolution of Open and Condensed Chromatin Landmarks
Anna A. Igolkina et al.
CELLS (2019)
Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma
Li Peng et al.
CANCER RESEARCH (2019)
HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription
Yifei Yuan et al.
ANTIVIRAL RESEARCH (2019)
Chromatin accessibility and the regulatory epigenome
Sandy L. Klemm et al.
NATURE REVIEWS GENETICS (2019)
ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis
Yun-Xin Lu et al.
CANCER RESEARCH (2018)
Dishevelled: A masterful conductor of complex Wnt signals
Monica Sharma et al.
CELLULAR SIGNALLING (2018)
Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis
Eunjeong Kim et al.
HEPATOLOGY (2018)
TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2
Zhanyao Tan et al.
ONCOGENE (2018)
Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus
Dvora Witt-Kehati et al.
TRANSLATIONAL ONCOLOGY (2018)
Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer
Mengyang Zhao et al.
CELL DEATH & DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A model of CSC converted from iPSC in the conditioned medium of HCC paving the way to establish HCC CSC
Said M. Afify et al.
CANCER RESEARCH (2018)
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
Yan-Yi Jiang et al.
GUT (2017)
Farnesoid X Receptor Ablation Sensitizes Mice to Hepatitis B Virus X Protein-Induced Hepatocarcinogenesis
Yongdong Niu et al.
HEPATOLOGY (2017)
Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis
Huairui Yuan et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen et al.
NATURE GENETICS (2017)
Models of human core transcriptional regulatory circuitries
Violaine Saint-Andre et al.
GENOME RESEARCH (2016)
Mechanisms of HBV-induced hepatocellular carcinoma
Massimo Levrero et al.
JOURNAL OF HEPATOLOGY (2016)
Active medulloblastoma enhancers reveal subgroup-specific cellular origins
Charles Y. Lin et al.
NATURE (2016)
Emerging concepts of epigenetic dysregulation in hematological malignancies
Panagiotis Ntziachristos et al.
NATURE IMMUNOLOGY (2016)
Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells
Zhongyuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION
Christopher D. O. Cooper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity
Seoung-Ae Lee et al.
MOLECULAR CANCER (2015)
Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Denes Hnisz et al.
MOLECULAR CELL (2015)
What are super-enhancers?
Sebastian Pott et al.
NATURE GENETICS (2015)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway
Qing Xie et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour et al.
SCIENCE (2014)
Transcription Factor Cooperativity in Early Adipogenic Hotspots and Super-Enhancers
Rasmus Siersbaek et al.
CELL REPORTS (2014)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Transcription factors: from enhancer binding to developmental control
Francois Spitz et al.
NATURE REVIEWS GENETICS (2012)
Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Maria Paula Ceballos et al.
BIOCHEMICAL PHARMACOLOGY (2011)
GABARAPL1 Negatively Regulates Wnt/beta-catenin Signaling by Mediating Dvl2 Degradation through the Autophagy Pathway
Yanquan Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Peter C. Hollenhorst et al.
GENES & DEVELOPMENT (2011)
The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection
Samuel Martin-Vilchez et al.
REVIEWS IN MEDICAL VIROLOGY (2011)
Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the bad
Kari Nichole Nejak-Bowen et al.
SEMINARS IN CANCER BIOLOGY (2011)
The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma
Richard Keld et al.
MOLECULAR CANCER (2010)
Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/β-catenin signaling pathway in hepatocellular carcinoma cells
Miran Kim et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells
Y-G Yoo et al.
ONCOGENE (2008)
WNT signaling pathway and stem cell signaling network
Masuko Katoh et al.
CLINICAL CANCER RESEARCH (2007)
Hepatitis B virus protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells
Juqiang Han et al.
NUCLEIC ACIDS RESEARCH (2006)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The developmental biology of Dishevelled: an enilgmatic protein governing cell fate and cell polarity
JB Wallingford et al.
DEVELOPMENT (2005)
Calcium signaling by HBx protein in hepatitis B virus DNA replication
MJ Bouchard et al.
SCIENCE (2001)
Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
TJ Koh et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
